News & Research
-
Who needs regular COVID-19 boosters?
A study led by researchers at Stanford Medicine finds the benefit of frequent booster vaccination for COVID-19 is highest for those over 65 years and the immunocompromised.
-
Bill Marshall dies at 92
The Stanford Medicine professor was well known as a mentor and teacher, as well as for his expertise in neuroradiology.
-
Digital health's future
Digital Health 2024 drew more than 200 attendees to hear from dozens of speakers on a range of topics at the intersection of health and digital technology.
-
Augmented reality in the OR
Stanford Medicine physician uses augmented reality to streamline data visualization during surgery.
-
Gift to help entrepreneurs
Longtime donor Li Ka-shing also provides support for leading faculty members.
-
Antonio Omuro is new neurology chair
The former chief of neuro-oncology at the Yale School of Medicine is a highly regarded scientist specializing in the study of brain tumors and an advocate of those underrepresented in medicine.
-
Drug lowers food allergy risk
A drug that binds to allergy-causing antibodies can protect children from dangerous reactions to accidentally eating allergy-triggering foods, a Stanford Medicine-led study found.
-
Women’s and men’s brain patterns differ
Stanford Medicine researchers have developed a powerful new artificial intelligence model that can distinguish between male and female brains.
-
Ketamine response may vary by sex
A new study in rats led by Stanford Medicine researchers looked at whether ketamine’s effects depend on opioid pathways — and uncovered a surprising difference between males and females.
-
Ensuring science integrity
At a convention on “future proofing” science, participants stressed that institutions can provide training, establish policies and create a culture that rewards rigorous and reproducible studies.
Stanford Medicine's blog about health, medicine, science & innovators.
Other Stanford
Medicine News
- – Stanford Report
Three faculty announced as HHMI investigators - Stanford Report
Three researchers join 21 other Stanford faculty as Howard Hughes Medical Institute investigators. The seven-year term frees faculty to pursue the most innovative biomedical research.